Role of living donor liver transplantation in the treatment of hepatitis C virus infection

authors:

avatar Georgios Tsoulfas 1 , * , avatar Polyxeni Agorastou 2

Department of Surgery, Aristoteleion University of Thessaloniki, tsoulfasg@msn.com, Greece
Department of Gastroenterology, Aristoteleion University of Thessaloniki, Greece
Hepatitis Monthly: Vol.11, issue 6; 427-433
article type: Review Article
received: January 2, 2011
accepted: April 17, 2011

how to cite: Tsoulfas G, Agorastou P. Role of living donor liver transplantation in the treatment of hepatitis C virus infection. Hepat Mon. 2011;11(6): 427-433. 

Abstract

Hepatitis C virus (HCV) infection is one of the most common indications for liver transplantation worldwide. Because of the existing organ shortage, adult-to-adult living donor liver transplantation (LDLT) has become an important method of expanding the donor pool to meet the ever-increasing need. However, despite advantages such as the quality of the hepatic graft and the timing of the transplant, the exact role of LDLT in the treatment of HCV is still unclear. In this review, we aim to address some of these issues in an effort to highlight both the advantages and disadvantages, as well as to identify the main challenges, of using LDLT for treating patients with HCV infection.

  • Implication for health policy/practice/research/medical education:
    This paper addresses the role of an important resource of society (living donor liver transplantation) in the treatment of a very difficult disease (hepatitis C virus infection).
  • Please cite this paper as:
    Tsoulfas G, Agorastou P. Role of living donor liver transplantation in the treatment of hepatitis C virus infection. Hepat Mon. 2011;11(6):427-33.

2011 Kowsar M.P.Co. All rights reserved.

Full Text

Full text is available in PDF